Hippocampal programmed cell death after status epilepticus: Evidence for NMDA-receptor and ceramide-mediated mechanisms

Epilepsia

Volumn 44, Issue 3, 2003, Pages 282-291

  Mikati, Mohamad A ^a   Abi Habib, Ralph J ^a   El Sabban, Marwan E ^a   Dbaibo, Ghassan S ^a   Kurdi, Rana M ^a   Kobeissi, Mohamad ^a   Farhat, Firas ^a   Asaad, Wissal ^a  

^a AMERICAN UNIVERSITY OF BEIRUT   (Lebanon)

Author keywords

Ceramide; Kainic acid; NMDA receptor; Programmed cell death; Status epilepticus

Indexed keywords

CERAMIDE; DIZOCILPINE; DNA FRAGMENT; KAINIC ACID; N METHYL DEXTRO ASPARTIC ACID RECEPTOR;

AGE; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; BLOOD LEVEL; CONTROLLED STUDY; DISEASE SEVERITY; EPILEPTIC STATE; HIPPOCAMPUS; NERVE INJURY; NERVOUS TISSUE; NONHUMAN; PRIORITY JOURNAL; RAT;

EID: 0037345852     PISSN: 00139580     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1528-1157.2003.22502.x     Document Type: Article

References (65)

1. Kerr JF, Wyllie AH, Currie AR. Apoptosis: a basic biological phenomenon with wide-ranging implications in tissue kinetics. Br J Cancer 1972;26:239-57.
2. Dragunow M, Preston K. The role of inducible transcription factors in apoptotic nerve cell death. Brain Res Rev 1995;21:1-28.
3. Kolesnick R, Fuks Z. Ceramide: a signal for apoptosis or mitogenesis? J Exp Med 1995;181:1949-52.
4. Fujikawa D, Shinmei S, Cai B. Kainic acid-induced seizures produce necrotic not apoptotic neurons with internucleosomal DNA cleavage: implications for programmed cell death mechanisms. Neuroscience 2000;98:41-53.
5. Weiss S, Cataltepe O, Cole AJ. Anatomical studies of DNA fragmentation in rat brain after systemic kainate administration. Neuroscience 1996;74:541-51.
6. Lopez E, Pozas E, Rivera R, et al. Bcl-2, Bax and Bcl-x expression following kainic acid administration at convulsant doses in the rat. Neuroscience 1999;91:1461-70.
7. Tuunanen J, Lukasiuk K, Halonen T, et al. Status epilepticus-induced neuronal damage in the rat amygdaloid complex: distribution, time course and mechanisms. Neuroscience 1999;94:473-95.
8. Covolan L, Smith RL, Mello LE. Ultrastructural identification of dentate granule cell death from pilocarpine-induced seizures. Epilepsy Res 2000;41:9-21.
9. Sloviter R, Dean E, Sollas A, et al. Apoptosis and necrosis induced in different hippocampal neuron populations by repetitive perforant path stimulation in the rat. J Comp Neurol 1996;366:516-33.
10. Gass P, Herdegen T, Bravo R, et al. Spatiotemporal induction of immediate early genes in the rat brain after limbic seizures: effects of NMDA receptor antagonist MK-801. Eur J Neurosci 1993;5:933-43.
11. Kroesen BJ, Pettus B, Luberto C, et al. Induction of apoptosis through B-cell receptor cross-linking occurs via de novo generated C 16-ceramide and involves mitochondria. J Biol Chem 2001;276:13606-14.
12. Selzner M, Bielawska A, Morse MA, et al. Induction of apoptotic cell death and prevention of tumor growth by ceramide analogues in metastatic human colon cancer. Cancer Res 2001;61:1233-40.
13. Hannun YA, Luberto C. Ceramide in the eukaryotic stress response. Trends Cell Biol 2000;10:73-80.
14. Kolesnick R, Hannun YA. Ceramide and apoptosis. Trends Biochem Sci 1999;4:224-5; discussion 227.
15. Dbaibo G, Hannun Y. Signal transduction and the regulation of apoptosis: roles of ceramide. Apoptosis 1998;3:317-34.
16. Liu YY, Han TY, Giuliano AE, et al. Glycosylation of ceramide potentiates cellular resistance to tumor necrosis factor-alpha-induced apoptosis. Exp Cell Res 1999;252:464-70.
17. Yu ZF, Nikolova-Karakashian M, Zhou D, et al. Pivotal role for acidic sphingomyelinase in cerebral ischemia-induced ceramide and cytokine production, and neuronal apoptosis. J Mol Neurosci 2000;15:85-97.
18. Chen Y, Ginis I, Hallenbeck JM. The protective effect of ceramide in immature rat brain hypoxia-ischemia involves up-regulation of bcl-2 and reduction of TUNEL-positive cells. J Cereb Blood Flow Metab 2001;21:34-40.
19. Puranam K, Qian WH, Nikbakht K, et al. Upregulation of Bcl-2 and elevation of ceramide in Batten disease. Neuropediatrics 1997; 28:37-41.
20. Holmes GL, Thompson JL, Marchi T, et al. Behavioral effects of kainic acid administration on the immature brain. Epilepsia 1988; 29:721-30.
21. Mikati MA, Holmes GL, Chronopoulos A, et al. Phenobarbital modifies seizure related brain injury in the developing brain. Ann Neurol 1994;36:425-33.
22. Liu W, Rong Y, Baudry M, et al. Status epilepticus induces p53 sequence-specific DNA binding in mature rat brain. Brain Res Mol Brain Res 1999;63:248-53.
23. Kondratyev A, Gale K. Temporal and spatial patterns of DNA fragmentation following focally or systemically-evoked status epilepticus in rats. Neurosci Lett 2001;310:13-6.
24. Bielawska A, Crane HM, Liotta D, et al. Selectivity of ceramidemediated biology: lack of activity of erythro-dihydroceramide. J Biol Chem 1993;268:26226-32.
25. Perry DK, Bielawska A, Hannun YA. Quantitative determination of ceramide using diglyceride kinase. Methods Enzymol 2000;312:22-31.
26. Fujikawa DG, Shinmei SS, Cai B. Seizure-induced neuronal necrosis: implications for programmed cell death mechanisms. Epilepsia 2000;41(suppl 6):S9-13.
27. Friedman LK. Selective reduction of GluR2 protein in adult hippocampal CA3 neurons following status epilepticus but prior to cell loss. Hippocampus 1998;8:511-25.
28. Kondratyev A, Gale K. Intracerebral injection of caspase-3 inhibitor prevents neuronal apoptosis after kainic acid-evoked status epilepticus. Brain Res Mol Brain Res 2000;75:216-24.
29. Thompson K, Holm AM, Schousboe A, et al. Hippocampal stimulation produces neuronal death in the immature brain. Neuroscience 1998;82:337-48.
30. Sankar R, Shin D, Liu H, et al. Patterns of status epilepticus-induced neuronal injury during development and long-term consequences. J Neurosci 1998;18:8382-93.
31. Santos NF, Marques RH, Correia L, et al. Multiple pilocarpine-induced status epilepticus in developing rats: a long term behavioral and electrophysiological study. Epilepsia 2000;41(suppl 6):S57-63.
32. Ribak CE, Baram TZ. Selective death of hippocampal CA3 pyramidal cells with mossy fiber afferents after CRH-induced status epilepticus in infant rats. Dev Brain Res 1996;91:245-51.
33. Holmes GL, Thompson JL. Effects of kainic acid on seizure susceptibility in the developing brain. Brain Res 1988;467:51-9.
34. Benchoua A, Guegan C, Couriaud C, et al. Specific caspase pathways are activated in the two stages of cerebral infarction. J Neurosci 2001;21:7127-34.
35. Hughes PE, Young D, Preston KM, et al. Differential regulation by MK801 of immediate-early genes, brain-derived neurotrophic factor and trk receptor mRNA induced by a kindling after-discharge. Brain Res Mol Brain Res 1998;53:138-51.
36. Zhang L, Mitani A, Yanase H, et al. Continuous monitoring and regulating of brain temperature in the conscious and freely moving ischemic gerbil: effect of MK-801 on delayed neuronal death in hippocampal CA1. J Neurosci Res 1997;47:440-8.
37. Toman RE, Spiegel S, Faden AI. Role of ceramide in neuronal cell death and differentiation. J Neurotrauma 2000;7:891-8.
38. Gill JS, Windebank AJ. Ceramide initiates NFkappaB-mediated caspase activation in neuronal apoptosis. Neurobiol Dis 2000;7:448-61.
39. Willaime S, Vanhoutte P, Caboche J, et al. Ceramide-induced apoptosis in cortical neurons is mediated by an increase in p38 phosphorylation and not by the decrease in ERK phosphorylation. Eur J Neurosci 2001;13:2037-46.
40. Monti B, Zanghellini P, Contestabile A. Characterization of ceramide-induced apoptotic death in cerebellar granule cells in culture. Neurochem Int 2001;39:11-8.
41. Hannun YA. Functions of ceramide in coordinating cellular responses to stress. Science 1996;274:1855-9.
42. Veldman RJ, Maestre N, Aduib OM, et al. A neutral sphingomyelinase resides in sphingolipid-enriched microdomains and is inhibited by the caveolin-scaffolding domain: potential implications in tumour necrosis factor signalling. Biochem J 2001;355:859-68.
43. Kolesnick RN, Goni FM, Alonso A. Compartmentalization of ceramide signaling: physical foundations and biological effects. J Cell Physiol 2000;184:285-300.
44. Sawai H, Hannun YA. Ceramide and sphingomyelinases in the regulation of stress responses. Chem Phys Lipids 1999;102:141-7.
45. Blazquez C, Galve-Roperh I, Guzman M. De novo-synthesized ceramide signals apoptosis in astrocytes via extracellular signalregulated kinase. FASEB J 2000;14:2315-22.
46. Herget T, Esdar C, Oehrlein SA, et al. Production of ceramides causes apoptosis during early neural differentiation in vitro. J Biol Chem 2000;275:30344-54.
47. Jayadev S, Barrett JC, Murphy E. Elevated ceramide is down-stream of altered calcium homeostasis in low serum-induced apoptosis. Am J Physiol Cell Physiol 2000;279:C1640-7.
48. Carmant L, Liu Z, Werner S, et al. Effect of kainic acid-induced status epilepticus on inositol-triphosphate and seizure-induced brain damage in mature and immature animals. Dev Brain Res 1995;89:67-72.
49. Huang RF, Huang SM, Lin BS, et al. Homocysteine thiolactone induces apoptotic DNA damage mediated by increased intracellular hydrogen peroxide and caspase 3 activation in HL-60 cells. Life Sci 2001;68:2799-811.
50. Marini M, Frabetti F, Canaider S, et al. Modulation of caspase-3 activity by zinc ions and by the cell redox state. Exp Cell Res 2001;266:323-32.
51. Zhou W, Zhang Y, Hosch MS, et al. Subcellular site of superoxide dismutase expression differentially controls AP-1 activity and injury in mouse liver following ischemia/reperfusion. Hepatology 2001;33:902-14.
52. Manna SK, Haridas V, Aggarwal BB. Bcl-x(L) suppresses TNF-mediated apoptosis and activation of nuclear factor-kappaB, activation protein-1, and c-Jun N-terminal kinase. J Interferon Cytokine Res 2000;20:725-35.
53. Hreniuk D, Garay M, Gaarde W, et al. Inhibition of c-Jun N-terminal kinase 1, but not c-Jun N-terminal kinase 2, suppresses apoptosis induced by ischemia/reoxygenation in rat cardiac myocytes. Mol Pharmacol 2001;59:867-74.
54. Wada K, Miyazawa T, Nomura N, et al. Mn-SOD and Bcl-2 expression after repeated hyperbaric oxygenation. Acta Neurochir Suppl 2000;76:285-90.
55. Choi WS, Lee EH, Chung CW, et al. Cleavage of Bax is mediated by caspase-dependent or -independent calpain activation in dopaminergic neuronal cells: protective role of Bcl-2. J Neurochem 2001;77:1531-41.
56. Decraene C, Brugg B, Ruberg M, et al. Identification of genes involved in ceramide-dependent neuronal apoptosis using cDNA arrays. Genome Biol 2002;3:0042.
57. Fariello RG, Golden GT, Smith GG, et al. Potentiation of kainic acid epileptogenicity and sparing from neuronal damage by an NMDA receptor antagonist. Epilepsy Res 1989;3:206-13.
58. Clifford DB, Olney JW, Benz AM, et al. Phencyclidine and MK801 protect against kainic acid-induced seizure-related brain damage. Epilepsia 1990;31:382-90.
59. Fujikawa DG, Daniels AH, Kim JS. The competitive NMDA receptor antagonist CGP 40116 protects against status epilepticus-induced neuronal damage. Epilepsy Res 1994;17:207-19.
60. Fujikawa DG. Neuroprotective effect of ketamine administered after status epilepticus onset. Epilepsia 1995;36:186-95.
61. Fujikawa DG, Shinmei SS, Cai B. Lithium-pilocarpine-induced status epilepticus produces necrotic neurons with internucleosomal DNA fragmentation in adult rats. Eur J Neurosci 1999;11:1605-14.
62. Ikonomidou C, Bosch F, Miksa M, et al. Blockade of NMDA receptors and apoptotic neurodegeneration in the developing brain. Science 1999;283:70-4.
63. Ikonomidou C, Bittigau P, Ishimaru MJ, et al. Ethanol-induced apoptotic neurodegeneration and fetal alcohol syndrome. Science 2000;287:1056-60.
64. Ishimaru MJ, Ikonomidou C, Tenkova TI, et al. Distinguishing excitotoxic from apoptotic neurodegeneration in the developing rat brain. J Comp Neurol 1999;408:461-76.
65. Fujikawa DG. Confusion between neuronal apoptosis and activation of programmed cell death mechanisms in acute necrotic insults. Trends Neurosci 2000;23:410-1.